Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Revenue

In the year 2025, Aligned Genetics had annual revenue of 16.02B KRW with 1.51% growth. Aligned Genetics had revenue of 4.28B in the quarter ending December 31, 2025, a decrease of -23.78%.

• Revenue: 16.02B
• Revenue Growth: +1.51%
• P/S Ratio: 3.81
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 60.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.02B	238.34M	1.51%
Dec 31, 2024	15.78B	562.88M	3.70%
Dec 31, 2023	15.21B	1.46B	10.63%
Dec 31, 2022	13.75B	1.99B	16.92%
Dec 31, 2021	11.76B	3.80B	47.82%